• Accueil >
  • Publications >
  • Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer

Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer

1 juil. 2018European Journal of Cancer

DOI : 10.1016/j.ejca.2018.03.008

Auteurs

Constance Thibault, Jean-Christophe Eymard, Alison Birtle, Michael Krainer, Giulia Baciarello, Aude Fléchon, Sylvestre Le Moulec, Dominique Spaeth, Brigitte Laguerre, Orazio Caffo, Jean-Laurent Deville, Phillipe Beuzeboc, Ali Hasbini, Marine Gross-Goupil, Carole Helissey, Mostefa Bennamoun, Anne-Claire Hardy-Bessard, Stéphane Oudard